Dr. Ganesh Jaishetwar

Dr. Ganesh Jaishetwar is a Senior Consultant Hematologist and Bone Marrow Transplant Physician with over 25 years of specialised clinical experience. He holds an MD and a DM in Clinical Hematology, complemented by a postdoctoral fellowship in BMT from the prestigious Tata Memorial Centre and advanced training in Leukemia and Bone Marrow Transplantation in Vancouver, Canada. He is a member of the American College of Physicians and maintains active memberships in major haematology societies globally.

Dr. Jaishetwar's clinical expertise spans the full spectrum of blood disorders and haematological malignancies, from acute and chronic leukemias to lymphomas, multiple myeloma, and myelodysplastic syndromes. He has successfully performed over 500 bone marrow transplants and pioneered several landmark procedures in India, including the first haploidentical BMT and the first ex vivo T-cell-depleted haploidentical BMT for adults in the country. His practice encompasses paediatric haematology, inherited blood disorders such as thalassaemia and sickle cell disease, and comprehensive haemophilia management.

At Yashoda Hospitals in Hi-Tech City, Hyderabad, Dr. Jaishetwar treats a significant volume of international patients from the Gulf region, Africa, and across South Asia. He is known for his meticulous patient-centred approach, taking time to explain complex treatment options and ensuring families remain involved in decision-making throughout their care journey. Many international patients appreciate his fluency in English and his ability to coordinate seamlessly with referring physicians abroad.

Yashoda Hospitals is a NABH-accredited facility with state-of-the-art haematology and oncology units, dedicated BMT wards with advanced isolation facilities, and an experienced international patient services team. The hospital's location in Hyderabad offers excellent connectivity and a lower cost of care compared to Western countries, without compromise on clinical standards. Dr. Jaishetwar's association with such a facility makes it an ideal destination for complex blood cancers and transplant procedures. International patients benefit from comprehensive pre-treatment consultation, streamlined logistics, and robust post-transplant follow-up both in-person and remotely.